Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Carlquist

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Journal of Thrombosis and Thrombolysis|May 26, 2010
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose predictionJohn F Carlquist, Benjamin D Horne, Chrissa Mower, et al.
American Heart Journal|August 10, 2005
Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery diseaseBryant M Whiting, Jeffrey L Anderson, Joseph B Muhlestein, et al.
American Heart Journal|January 6, 2005
Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetesMatthew J Kolek, John F Carlquist, Joseph B Muhlestein, et al.
Circulation|January 23, 2003
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary diseaseBenjamin D Horne, Joseph B Muhlestein, John F Carlquist, et al.
The American Journal of Cardiology|November 3, 2004
Early effects of statins in patients with coronary artery disease and high C-reactive proteinJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.
The American Journal of Cardiology|March 20, 2012
Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiographyBenjamin D Horne, Joseph B Muhlestein, Heidi T May, et al.
American Heart Journal|June 24, 2010
Association of vitamin D levels with incident depression among a general cardiovascular populationHeidi T May, Tami L Bair, Donald L Lappé, et al.
American Heart Journal|December 9, 2003
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery diseaseJohn F Carlquist, Joseph B Muhlestein, Benjamin D Horne, et al.
Atherosclerosis|October 19, 2004
Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36John F Carlquist, Joseph B Muhlestein, Benjamin D Horne, et al.
The American Journal of Medicine|October 27, 2004
Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery diseaseLillian L C Khor, Joseph B Muhlestein, John F Carlquist, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Journal of Thrombosis and Thrombolysis|May 26, 2010
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose predictionJohn F Carlquist, Benjamin D Horne, Chrissa Mower, et al.
American Heart Journal|August 10, 2005
Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery diseaseBryant M Whiting, Jeffrey L Anderson, Joseph B Muhlestein, et al.
American Heart Journal|January 6, 2005
Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetesMatthew J Kolek, John F Carlquist, Joseph B Muhlestein, et al.
Circulation|January 23, 2003
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary diseaseBenjamin D Horne, Joseph B Muhlestein, John F Carlquist, et al.
The American Journal of Cardiology|November 3, 2004
Early effects of statins in patients with coronary artery disease and high C-reactive proteinJoseph B Muhlestein, Jeffrey L Anderson, Benjamin D Horne, et al.
The American Journal of Cardiology|March 20, 2012
Relation of routine, periodic fasting to risk of diabetes mellitus, and coronary artery disease in patients undergoing coronary angiographyBenjamin D Horne, Joseph B Muhlestein, Heidi T May, et al.
American Heart Journal|June 24, 2010
Association of vitamin D levels with incident depression among a general cardiovascular populationHeidi T May, Tami L Bair, Donald L Lappé, et al.
American Heart Journal|December 9, 2003
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery diseaseJohn F Carlquist, Joseph B Muhlestein, Benjamin D Horne, et al.
Atherosclerosis|October 19, 2004
Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36John F Carlquist, Joseph B Muhlestein, Benjamin D Horne, et al.
The American Journal of Medicine|October 27, 2004
Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery diseaseLillian L C Khor, Joseph B Muhlestein, John F Carlquist, et al.
Pageof 9